Last €5.64 EUR
Change Today +0.204 / 3.76%
Volume 0.0
RYIN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 2:20 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - sunesis pharmaceuticals inc (RYIN)

NameBoard RelationshipsTitleAge
Daniel N. Swisher Jr.14 RelationshipsChief Executive Officer, President and Director51
Eric H. Bjerkholt 16 RelationshipsChief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary54
Adam R. Craig M.D., Ph.D., M.B.A.No RelationshipsChief Medical Officer and Executive Vice President of Development48
Joseph I. DePinto No RelationshipsChief Commercial Officer and Executive Vice President47

Board Members - sunesis pharmaceuticals inc (RYIN)

NameBoard RelationshipsPrimary CompanyAge
James W. Young Ph.D.51 Relationships5AM Venture Management LLC69
Daniel N. Swisher Jr.14 RelationshipsSunesis Pharmaceuticals, Inc.51
Matthew K. Fust 37 RelationshipsSunesis Pharmaceuticals, Inc.49
Homer L. Pearce Ph.D.76 RelationshipsPearl Street Venture Funds61
Dayton Misfeldt 26 RelationshipsBay City Capital LLC40

Executive Committees* - sunesis pharmaceuticals inc (RYIN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMatthew K. Fust 37 Relationships3 Executives
Compensation CommitteeDayton Misfeldt 26 Relationships3 Executives
Nominating CommitteeHomer L. Pearce Ph.D. 76 Relationships2 Executives
Corporate Governance CommitteeHomer L. Pearce Ph.D. 76 Relationships2 Executives
View RYIN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RYIN:GR €5.64 EUR +0.204

RYIN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
NeurogesX Inc $0.0048 USD -0.0022
POZEN Inc $8.32 USD -0.05
View Industry Companies
 

Industry Analysis

RYIN

Industry Average

Valuation RYIN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 56.7x
Price/Book 28.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 47.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.